slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 27,811-27,840
Pages 1,379
Rows per page 30
Component
27,811-27,840 of 41,369
05
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Beat · Problem & Complication1 hit
06
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Beat · Problem & Complication1 hit
27
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
28
The slide uses a two-column list structure to categorize launch activities.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
29
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
31
The bridge chart illustrates the path from 7% to ~25% margin using three levers: commercial operating leverage, R&D prioritization, and G&A/manufacturing efficiency.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
36
The slide uses a 2x2-style grid layout to contrast commercial products with development pipeline candidates.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
48
The slide highlights a tech stack including KNIME, Docker, AWS, and RDKit integrated into a proprietary platform.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
68
The slide uses a structured clinical case format to demonstrate drug efficacy.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
73
The table tracks individual patient outcomes (OC1-OC5) in a platinum-resistant ovarian cancer cohort.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
78
The slide uses a three-column layout to summarize clinical safety data.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
79
The slide highlights the efficacy of the SC 3 mg q7d regimen in expanding effector cells compared to IV administration.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
80
The slide outlines the transition from dose escalation cohorts (q7d and q21d) to a specific Phase 2 expansion cohort at 3.0 mg q7d.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
81
Patient profile includes diagnosis, prior treatment history, current study activity, and clinical outcomes.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
89
The slide uses a chevron-based process flow to show the transition from preclinical to clinical research.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
103
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
126
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
128
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
130
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
15
The slide uses a combination of a bar chart for market growth and a map for penetration rates.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank Beat · ProblemLoop · Zoom In1 hit
19
The slide uses a dual-track timeline to contrast Anghami's local growth with the entry of international players.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
20
The slide uses a map-based visualization to show regional artist distribution and highlights specific metrics for Arabic content performance.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
24
Uses a hub-and-spoke style diagram to connect the central data capability to five specific business outcomes.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
31
The slide highlights a conversion mechanism between the two revenue streams.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
47
The slide highlights the sponsor's (Vistas Media) expertise across media, finance, and governance.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank Beat · Team1 hit
30
The slide uses a sum-of-the-parts (SOTP) methodology to derive an implied share price.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Solution & Approach1 hit
40
The slide uses a numbered list format to structure the valuation arguments.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Evidence & Proof1 hit
05
The slide combines clinical data points with human-centric patient stories to build credibility.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
08
The slide outlines a multi-stage clinical trial process including a Go/No Go decision point.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
09
The slide outlines the dosing schedule (weeks 1-4, 5-16, and beyond) and the primary objective for the trials.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit